8-K: BrightSpring Health Services to Divest Community Living Business for $835 Million; Announces Preliminary 2024 Results and 2025 Guidance

BrightSpring Health Services has entered into an agreement to sell its Community Living business to Sevita for $835 million, focusing on core growth areas and debt reduction.

Summary

• BrightSpring Health Services has agreed to divest its Community Living business to Sevita for $835 million in cash, subject to adjustments.
• The transaction is expected to close in 2025, pending regulatory approvals and customary closing conditions.
• The Community Living business generated approximately $1.2 billion in revenue and $128 million in Adjusted EBITDA in 2024, with $23 million in capital expenditures.
• BrightSpring anticipates receiving approximately $715 million in after-tax cash proceeds from the sale, which will be used primarily for debt reduction.
• The company expects the divestiture to enhance its revenue and Adjusted EBITDA growth rates, as well as improve cash conversion.
• BrightSpring's Provider Services segment will focus on Home Health and Hospice, Personal Care, Rehabilitation Services, and Primary Care.
• Preliminary 2024 results indicate revenue between $11.2 billion and $11.3 billion, and Adjusted EBITDA of approximately $588 million.
• For 2025, BrightSpring projects revenue between $11.5 billion and $12 billion, and Adjusted EBITDA between $540 million and $555 million, excluding the divested Community Living business.

Sentiment

Score: 8

Explanation: The document conveys a positive outlook with the divestiture seen as a strategic move to enhance growth and financial stability. The preliminary 2024 results and 2025 guidance are also positive, indicating strong performance and future potential.

Positives

• The divestiture allows BrightSpring to focus on higher-growth areas like home health and hospice.
• Debt reduction will strengthen the company's balance sheet and reduce interest expenses.
• The transaction is expected to be accretive to both Company and Provider Services Revenue growth and Adjusted EBITDA growth.
• The streamlined service offerings will result in increased strategic focus and operational efficiencies.
• The company expects to maximize exposure to target growth markets.

Negatives

• The divestiture will result in a reduction of revenue and EBITDA from the Community Living business.
• The company will need to manage the transition of 13,500 employees to Sevita.
• The company will need to manage the transition of 14,000 clients to Sevita.

Risks

• The transaction is subject to regulatory approvals and customary closing conditions, which could delay or prevent the sale.
• There is a risk of potential disruptions during the transition of the Community Living business to Sevita.
• The company's ability to achieve projected growth rates and operational efficiencies is subject to various market and economic factors.
• The company's ability to successfully execute its strategy in the remaining service lines is subject to various market and economic factors.

Future Outlook

BrightSpring expects the divestiture to enhance its revenue and Adjusted EBITDA growth rates and maximize exposure to target growth markets. The company also anticipates accelerated deleveraging and increased capital availability.

Management Comments

• Jon Rousseau, Chairman, President and Chief Executive Officer of BrightSpring, stated that the divestiture will allow the company to focus on a concentrated group of customers and stakeholders.
• Rousseau also noted that the streamlined service offerings will result in increased strategic focus and operational efficiencies.
• Philip Kaufman, CEO of Sevita, expressed excitement about partnering with ResCare Community Living and continuing to provide quality community-based health care.

Industry Context

This divestiture reflects a trend in the healthcare industry towards specialization and focusing on core competencies. BrightSpring is streamlining its operations to concentrate on high-growth areas, while Sevita is expanding its presence in the I/DD sector.

Comparison to Industry Standards

• The divestiture of the Community Living business for $835 million is a significant transaction in the home and community-based healthcare sector.
• The valuation of the business at approximately 0.7x revenue and 6.5x EBITDA is within the range of comparable transactions in the sector.
• The focus on debt reduction and strategic growth areas aligns with industry trends of optimizing capital allocation and improving financial performance.
• The projected growth rates for the remaining business segments are competitive with industry benchmarks for home health, hospice, and personal care services.
• Comparable companies in the home health and hospice space include LHC Group and Amedisys, which have also seen strong growth and consolidation activity.

Stakeholder Impact

• Shareholders are expected to benefit from the increased strategic focus, improved financial performance, and debt reduction.
• Employees in the Community Living business will transition to Sevita.
• Clients of the Community Living business will continue to receive services under Sevita.
• Customers and patients in the remaining service lines will benefit from the company's increased focus and investment in those areas.
• Creditors will benefit from the company's accelerated deleveraging.

Next Steps

• The transaction is expected to close in 2025, pending regulatory approvals and customary closing conditions.
• BrightSpring will focus on its remaining service lines and operational efficiencies.
• The company will use the proceeds from the sale to reduce debt.
• BrightSpring will continue to execute its strategic plan in the remaining service lines.

Key Dates

Keywords

divestiture, community living, Sevita, BrightSpring Health Services, home health, hospice, personal care, rehabilitation services, pharmacy solutions, adjusted EBITDA, debt reduction, healthcare, intellectual and developmental disabilities